Table 4.

Respiratory management of post-LDLT pneumonia

Case	LDLT	Age/gender	Primary disease	ABO	MELD	Splenectomy performed	Initial diagnosis of pneumonia (days after LDLT)	Pneumonia pathogen	Final diagnosis of IPA	Outcome	Months after LDLT
1	Emergent	47/M	HBV-LC	Incompatible	31.9	(+)	1	Ps. aeruginosa	–	Survived	29.9
2	Emergent	52/F	HBV-LC	Incompatible	23.7	(+)	0	MRSA	–	Died	2.4
3	Emergent	52/F	FHF	Identical	18.9	(−)	22	A. fumigatus	Proven	Died	3.1
4	Emergent	52/F	PBC	Identical	36.5	(−)	1	A. terreus	Probable	Died	3.6
5	Emergent	53/F	FHF	Compatible	20.2	(−)	0	A. fumigatus	Proven	Survived	57.5
6	Elective	66/M	HCC	Incompatible	9.0	(+)	5	E. faecalis	–	Survived	26.3

M male, F female, HBV-LC hepatitis B virus-liver cirrhosis, FHF fulminant hepatic failure, PBC primary biliary cirrhosis, HCC hepatocellular carcinoma, MELD model for end-stage liver disease, LDLT living donor liver transplantation, Ps. aeruginosa Pseudmonous aeruginosa, MRSA methicillin-resistant Staphylococcus aureus, A. fumigatus Aspergillus fumigatus, A. terreus Aspergillus terreus, E. faecalis Enterococcus faecalis, IPA invasive pulmonary aspergillosis